Immune cell phenotype and functional defects in Netherton syndrome
Authors:
- Elina EränköEEElina Eränkö
- Mette IlanderMIMette Ilander
- Mirja TuomirantaMTMirja Tuomiranta
- Antti MäkitieAMAntti Mäkitie
- Tea LassilaTLTea Lassila
- Anna KreutzmanAKAnna Kreutzman
- Paula KlemettiPKPaula Klemetti
- Satu MustjokiSMSatu Mustjoki
- Katariina Hannula-JouppiKHKatariina Hannula-Jouppi
- Annamari RankiARAnnamari Ranki
Open Access
- 26 November 2018
- journal article
- research article
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 13 (1) , 213
Abstract
Netherton syndrome (NS) is a rare life-threatening syndrome caused by SPINK5 mutations leading to a skin barrier defect and a severe atopic diathesis. NS patients are prone to bacterial infections, but the understanding of the underlying immune deficiency is incomplete. We analyzed blood lymphocyte phenotypes and function in relation to clinical infections in 11 Finnish NS patients, aged 3 to 17 years, and healthy age-matched controls. The proportion of B cells (CD19+) and naïve B cells (CD27−, IgD+) were high while memory B cells (CD27+) and switched memory B cells (CD27+IgM−IgD−), crucial for the secondary response to pathogens, was below or in the lowest quartile of the reference values in 8/11 (73%) and 9/11 (82%) patients, respectively. The proportion of activated non-differentiated B cells (CD21low, CD38low) was below or in the lowest quartile of the reference values in 10/11 (91%) patients. Despite normal T cell counts, the proportion of naïve CD4+ T cells was reduced significantly and the proportion of CD8+ T central memory significantly elevated. An increased proportion of CD57+ CD8+ T cells indicated increased differentiation potential of the T cells. The proportion of cytotoxic NK cells was elevated in NS patients in phenotypic analysis based on CD56DIM, CD16+ and CD27− NK cells but in functional analysis, decreased expression of CD107a/b indicated impaired cytotoxicity. The T and NK cell phenotype seen in NS patients also significantly differed from that of age-matched atopic dermatitis (AD) patients, indicating a distinctive profile in NS. The frequency of skin infections correlated with the proportion of CD62L+ T cells, naïve CD4+ and CD27+ CD8+ T cells and with activated B cells. Clinically beneficial intravenous immunoglobulin therapy (IVIG) increased naïve T cells and terminal differentiated effector memory CD8+ cells and decreased the proportion of activated B cells and plasmablasts in three patients studied. This study shows novel quantitative and functional aberrations in several lymphocyte subpopulations, which correlate with the frequency of infections in patients with Netherton syndrome. IVIG therapy normalized some dysbalancies and was clinically beneficial.Keywords
Funding Information
- Sigrid Juséliuksen Säätiö
- Allergy Research Foundation
- Helsingin ja Uudenmaan Sairaanhoitopiiri
- Finska Läkaresällskapet
- Suomen Ihotautilääkäriyhdistys
This publication has 26 references indexed in Scilit:
- CD57 in human natural killer cells and T-lymphocytesCancer Immunology, Immunotherapy, 2016
- IgE allergen component-based profiling and atopic manifestations in patients with Netherton syndromeJournal of Allergy and Clinical Immunology, 2014
- B‐cell subpopulations in children: National reference valuesImmunity, Inflammation and Disease, 2014
- Why do we need IgM memory B cells?Immunology Letters, 2013
- Common Variable Immune Deficiency in Children—Clinical Characteristics Varies Depending on Defect in Peripheral B Cell MaturationJournal of Clinical Immunology, 2013
- Comèl-Netherton syndrome defined as primary immunodeficiencyJournal of Allergy and Clinical Immunology, 2009
- CD27 Defines Phenotypically and Functionally Different Human NK Cell SubsetsThe Journal of Immunology, 2008
- CD27 and CD70 in T cell and B cell activationCurrent Opinion in Immunology, 2005
- Autoimmune Regulator Is Expressed in the Cells Regulating Immune Tolerance in Thymus MedullaBiochemical and Biophysical Research Communications, 1999
- Selective Antibody Deficiency to Bacterial Polysaccharide Antigens in Patients with Netherton SyndromePediatric Dermatology, 1999